Biotechnology

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of…

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, will be reporting third-quarter results today at 4:00 p.m. ET.…

Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The…

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is scheduled to publish earnings for the third quarter of 2023, today at…

Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third…

Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023.…

Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also…

Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced third-quarter 2023 earnings results, reporting a sharp increase in revenues…

Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) entered into a joint venture with Virion Therapeutics, LLC, to expedite and expand…

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in…

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries…

Key highlights from Illumina, Inc (ILMN) Q2 2023 Earnings Concall Management Update: [00:07:42] ILMN now expects to ship more than…

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday provided an update on its broad range of programs in malaria, fibrosis, and…

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023. Second-quarter revenue came…

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter…

Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim…

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023.…

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday shared collective analyst research coverage from three firms, with current Buy recommendations and…

Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Tuesday announced financial results for the fourth quarter of 2023, reporting an increase…

Animal healthcare company Zoetis Inc. (NYSE: ZTS) announced operating results for the second quarter, reporting higher adjusted profit and sales.…

Amgen Inc. (NASDAQ: AMGN) on Friday reported higher revenues and adjusted earnings for the second quarter of 2023. The biotechnology…